UNYQ Inc, a provider of 3D-printed prosthetic covers, has entered into a distribution partnership with Southern Prosthetic Supply Inc (SPS), a distributor of orthotic and prosthetic products in the United States, it announces.
The wireless, wearable LEAF Patient Monitoring System has monitored more than 60,000 patients with over 7 million hours of use, helping to reduce the economic and human costs of pressure injuries, according to Smith+Nephew, its distributor, in a media release.
Acute kidney injury (AKI) occurred in nearly 20% of patients who underwent surgery with implantation of antibiotic-loaded "spacers" and intravenous (IV) antibiotics for the treatment of deep infections after total knee arthroplasty, reports a study in The Journal of Bone & Joint Surgery.
Researchers from Massachusetts Institute of Technology (MIT) have invented a new type of amputation surgery that can help amputees to better control their residual muscles and sense where their "phantom limb" is in space.
Soaking in a hot tub for 60 minutes may provide similar post-activity cardiovascular benefits as 60 minutes of cycling. This news could help people who are not able to exercise due to their health, according to University of Oregon researchers, in a study published in Journal of Applied Physiology.
The U.S. Food and Drug Administration has authorized the marketing of the Portable Neuromodulation Stimulator (PoNS), a new device indicated for use as a short-term treatment of gait deficit due to mild to moderate symptoms from multiple sclerosis (MS).
Recovery Force LLC has received US Food and Drug Administration (FDA) 510(k) clearance for the use of the Movement and Compressions (MAC) System, a novel, data-driven, mobility measurement device designed for hospital and home use.
Taking into consideration the costs of forgoing versus pursuing total knee replacement, researchers suggest that across older and younger age groups, the procedure is a cost-effective treatment for these patients.
Researchers at Indiana University School of Medicine have successfully reprogrammed a glial cell type in the central nervous system into new neurons to promote recovery after spinal cord injury--revealing an untapped potential to leverage the cell for regenerative medicine.